Eminence Organics
MAY 9, 2024
What Does Sun Damaged Skin Look Like? Years of spending time outdoors in the sun will take a toll on our skin. The hours and days we’ve logged exposed to the elements can be seen in dark spots, wrinkles, sagging skin and discoloration. Unfortunately for sun lovers, sun damage can age our skin prematurely and increase our risk of developing skin cancer.
Beautiful With Brains - Antiaging
MAY 9, 2024
Have you been using retinol for a while and are now ready to up your dose? After years of dabbling with entry-level dose, I was ready to uplevel to Skinceuticals 0.5 Retinol Refining Cream. 0.5% is a good concentration for intermediate users. And one that’s hard to find. Most products out there either give you […] The post Is Skinceuticals Retinol 0.5 Refining Night Cream Worth The Splurge?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Beauty Launchpad
MAY 9, 2024
Using an American-made Salon Mat is an effective way to reduce industry burnout. Smart Step Premium Standing Solutions are synonymous with a healthy work-life balance. Our Granite Collection offers creativity, while taking care of today’s stylists.
Dermatology Times
MAY 9, 2024
Patients who responded to imsidolimab in GEMINI-1 and who moved into GEMINI-2 maintained clear or almost clear skin.
The Dermatology Digest
MAY 9, 2024
A microneedle patch that delivers immune-regulating molecules may teach T cells not to attack hair follicles, helping regrow hair in alopecia areata, according to research in mice from MIT, Brigham and Women’s Hospital, and Harvard Medical School. The team developed a microneedle patch that can be painlessly applied to the scalp and releases drugs that help to rebalance the immune response at the site, halting the autoimmune attack.
Dermatology Times
MAY 9, 2024
Researchers explored the risk of SPM in patients of different races with the rare type of tumor of the skin.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
MAY 9, 2024
Authors of a recent review concluded that combining various therapies holds promise in the treatment of acne scarring.
Salon Today
MAY 9, 2024
WHY JOIN AVEDA? BECAUSE WE CARE.
Dermatology Times
MAY 9, 2024
VYNE expects to enroll the first patient with vitiligo in the phase 2b trial for VYN201 in the second quarter of 2024.
Beauty Launchpad
MAY 9, 2024
Amanda Lyberger (@thehairygodmotherr) is a hair colorist at Thair Salon in Los Angeles, CA.
Dermatology Times
MAY 9, 2024
Leading dermatologists explore key benchmarks, emerging trends, personalized medicine approaches, and more in atopic dermatitis.
Skin Inc
MAY 9, 2024
The Cut It Out program is designed to provide licensed professionals, students and others in the beauty industry with the resources they need to combat the widespread issue of domestic abuse.
Dermatology Times
MAY 9, 2024
This Skin Cancer Awareness Month, we have compiled a list of resources for clinicians to share with their patients.
Spa Industry Association
MAY 9, 2024
Allan chats with our recurring guest Shannon Blake from Podium! They cover: Reviews and what great, 5 star reviews are so important How to deal with negative reviews When leads slow down, you need a good pipeline Podium’s 1 phone number makes life simple Speak in response is critical Get it on: iTunes Podbean Spotify Continue reading Flock and Gather Podcast.
The Dermatology Digest
MAY 9, 2024
Generalized pustular psoriasis (GPP) patients who responded to AnaptysBio, Inc.’s investigational imsidolimab (IL-36R mAb) in GEMINI-1 and moved into GEMINI-2 maintained clear or almost clear skin through at Week 24, according to topline results reported by the Company. In the 45-patient GEMINI-1 Phase 3 trial, patients were randomized 1:1:1 to receive a single infusion of 750mg intravenous (IV) imsidolimab, 300mg IV imsidolimab or placebo at Day 0.
The Dermatology Digest
MAY 9, 2024
Hidradenitis Suppurativa (HS) patient receiving adalimumab (Humira, AbbVie) show improvements in anemia, thrombocytosis, and leukocytosis, and these improvements can be seen in clinical responders and nonresponders, according to post hoc analyses of two phase 3 trials published in JAMA Dermatology. The new findings build on a previous study in a smaller cohort of HS patients that also documented improvements in anemia, leukocytosis, or thrombocytosis after immunomodulatory therapy.
Expert insights. Personalized for you.
98 
Let's personalize your content